Table of Contents Author Guidelines Submit a Manuscript
Journal of Drug Delivery
Volume 2014, Article ID 948650, 7 pages
http://dx.doi.org/10.1155/2014/948650
Research Article

Application of Experimental Design in Preparation of Nanoliposomes Containing Hyaluronidase

Department of Pharmaceutical Biotechnology, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal 576 104, India

Received 30 May 2014; Accepted 15 August 2014; Published 9 September 2014

Academic Editor: Juan M. Irache

Copyright © 2014 Narayanan Kasinathan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. R. E. Fraser, T. C. Laurent, and U. B. G. Laurent, “Hyaluronan: its nature, distribution, functions and turnover,” Journal of Internal Medicine, vol. 242, no. 1, pp. 27–33, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. K. S. Girish and K. Kemparaju, “The magic glue hyaluronan and its eraser hyaluronidase: a biological overview,” Life Sciences, vol. 80, no. 21, pp. 1921–1943, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. S. H. Bailey, S. Fagien, and R. J. Rohrich, “Changing role of hyaluronidase in plastic surgery,” Plastic and Reconstructive Surgery, vol. 133, no. 2, pp. 127e–132e, 2014. View at Google Scholar
  4. H. Rüschen, L. Adams, and C. Bunce, “Use of hyaluronidase as an adjunct to local anaesthetic eye blocks (Protocol),” Cochrane Database of Systematic Reviews, no. 2, Article ID CD010368, pp. 1–15, 2013. View at Google Scholar
  5. P. Kaur Chugh and V. Roy, “Biosimilars: current scientific and regulatory considerations,” Current Clinical Pharmacology, vol. 9, no. 1, pp. 53–63, 2014. View at Google Scholar
  6. N. Kohno, T. Ohnuma, and P. Truog, “Effects of hyaluronidase on doxorubicins penetration into squamous carcinoma multicellular tumor spheroids and its cell lethality,” Journal of Cancer Research and Clinical Oncology, vol. 120, no. 5, pp. 293–297, 1994. View at Publisher · View at Google Scholar · View at Scopus
  7. L. E. Clark and J. R. Mellette Jr., “The use of hyaluronidase as an adjunct to surgical procedures,” The Journal of Dermatologic Surgery and Oncology, vol. 20, no. 12, pp. 842–844, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Shariat, A. Badiee, M. R. Jaafari, and S. A. Mortazavi, “Optimization of a method to prepare liposomes containing HER2/Neu-derived peptide as a vaccine delivery system for breast cancer,” Iranian Journal of Pharmaceutical Research, vol. 13, pp. 15–25, 2014. View at Google Scholar
  9. R. A. Lionberger, S. L. Lee, L. Lee, A. Raw, and L. X. Yu, “Quality by design: concepts for ANDAs,” The AAPS Journal, vol. 10, no. 2, pp. 268–276, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. V. Czitrom, “One-factor-at-a-time versus designed experiments,” The American Statistician, vol. 53, no. 2, pp. 126–131, 1999. View at Google Scholar · View at Scopus
  11. Guideline ICHHT, Pharmaceutical development. Q8 (2R), August 2009.
  12. J. N. Sangshetti, M. Deshpande, R. Arote, Z. Zaheer, and D. B. Shinde, “Quality by design approach: regulatory need,” Arabian Journal of Chemistry, 2014. View at Publisher · View at Google Scholar
  13. J. K. Telford, “A brief introduction to design of experiments,” Johns Hopkins APL Technical Digest, vol. 27, no. 3, pp. 224–232, 2007. View at Google Scholar · View at Scopus
  14. B. D. Loveymi, M. Jelvehgari, P. Zakeri-Milani, and H. Valizadeh, “Statistical optimization of oral vancomycin-eudragit RS nanoparticles using response surface methodology,” Iranian Journal of Pharmaceutical Research, vol. 11, no. 4, pp. 1001–1012, 2012. View at Google Scholar · View at Scopus
  15. L. N. Ramana, S. Sethuraman, U. Ranga, and U. M. Krishnan, “Development of a liposomal nanodelivery system for nevirapine,” Journal of Biomedical Science, vol. 17, no. 1, article 57, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, “Protein measurement with the Folin phenol reagent,” The Journal of Biological Chemistry, vol. 193, no. 1, pp. 265–275, 1951. View at Google Scholar · View at Scopus
  17. G. Adrian and L. Huang, “Entrapment of proteins in phosphatidylcholine vesicles,” Biochemistry, vol. 18, no. 25, pp. 5610–5614, 1979. View at Publisher · View at Google Scholar · View at Scopus
  18. A. S. Abreu, E. M. S. Castanheira, M.-J. R. P. Queiroz, P. M. T. Ferreira, L. A. Vale-Silva, and E. Pinto, “Nanoliposomes for encapsulation and delivery of the potential antitumoral methyl 6-methoxy-3-(4-methoxyphenyl)-1H-indole-2-carboxylate,” Nanoscale Research Letters, vol. 6, article 482, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. F. M. Cagdas, N. Ertugral, S. Bucak, and N. Z. Atay, “Effect of preparation method and cholesterol on drug encapsulation studies by phospholipid liposomes,” Pharmaceutical Development and Technology, vol. 16, no. 4, pp. 408–414, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Haeri, B. Alinaghian, M. Daeihamed, and S. Dadashzadeh, “Preparation and characterization of stable nanoliposomal formulation of fluoxetine as a potential adjuvant therapy for drug-resistant tumors,” Iranian Journal of Pharmaceutical Research, vol. 13, pp. 3–14, 2014. View at Google Scholar
  21. M. Ning, Z. Gu, H. Pan, H. Yu, and K. Xiao, “Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antifungal drug clotrimazole,” Indian Journal of Experimental Biology, vol. 43, no. 2, pp. 150–157, 2005. View at Google Scholar · View at Scopus
  22. A. Bhatia, R. Kumar, and O. P. Katare, “Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation,” Journal of Pharmacy and Pharmaceutical Sciences, vol. 7, no. 2, pp. 252–259, 2004. View at Google Scholar · View at Scopus